Recombinant LAG3 (Relatlimab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all LAG3 (Relatlimab Biosimilar) products
- LAG3 (Relatlimab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This LAG3 (Relatlimab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Relatlimab Biosimilar Antibody
- Specificity
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG4 kappa
-
anti-LAG3 (Relatlimab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 7.5 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- LAG3 (Relatlimab Biosimilar)
- Alternative Name
- Relatlimab Biosimilar (LAG3 (Relatlimab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
- UniProt
- P18627
- CAS-No
- 1673516-98-7
-
You are here:
